BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 33762128)

  • 1. Metabolic effects of bariatric surgery on patients with type 2 diabetes: a population-based study.
    Akpinar EO; Liem RSL; Nienhuijs SW; Greve JWM; Marang-van de Mheen PJ;
    Surg Obes Relat Dis; 2021 Jul; 17(7):1349-1358. PubMed ID: 33762128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight recurrence after Sleeve Gastrectomy versus Roux-en-Y gastric bypass: a propensity score matched nationwide analysis.
    Akpinar EO; Liem RSL; Nienhuijs SW; Greve JWM; Marang-van de Mheen PJ;
    Surg Endosc; 2023 Jun; 37(6):4351-4359. PubMed ID: 36745232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleeve gastrectomy and Roux-en-Y gastric bypass in the treatment of type 2 diabetes. Two-year results from a Swedish multicenter randomized controlled trial.
    Wallenius V; Alaraj A; Björnfot N; Orrenius B; Kylebäck A; Björklund P; Werling M; Thorell A; Fändriks L; Maleckas A
    Surg Obes Relat Dis; 2020 Aug; 16(8):1035-1044. PubMed ID: 32540150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of 1-year outcomes between Roux-en-Y gastric bypass and sleeve gastrectomy with Roux-en-Y duodenojejunal bypass in the patients of obesity with type 2 diabetes mellitus].
    Liang H; Si YM; Lin SB; Shen JJ; Guan W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Nov; 26(11):1051-1057. PubMed ID: 37974350
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of early type 2 diabetes improvement after gastric bypass and sleeve gastrectomy: medication cessation at discharge predicts 1-year outcomes.
    Heshmati K; Harris DA; Aliakbarian H; Tavakkoli A; Sheu EG
    Surg Obes Relat Dis; 2019 Dec; 15(12):2025-2032. PubMed ID: 31711946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bariatric procedure selection in patients with type 2 diabetes: choice between Roux-en-Y gastric bypass or sleeve gastrectomy.
    Aminian A
    Surg Obes Relat Dis; 2020 Feb; 16(2):332-339. PubMed ID: 31902579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Safety and Effectiveness of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Weight Loss and Type 2 Diabetes Across Race and Ethnicity in the PCORnet Bariatric Study Cohort.
    Coleman KJ; Wellman R; Fitzpatrick SL; Conroy MB; Hlavin C; Lewis KH; Coley RY; McTigue KM; Tobin JN; McBride CL; Desai JR; Clark JM; Toh S; Sturtevant JL; Horgan CE; Duke MC; Williams N; Anau J; Horberg MA; Michalsky MP; Cook AJ; Arterburn DE; Apovian CM;
    JAMA Surg; 2022 Oct; 157(10):897-906. PubMed ID: 36044239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of early severe postoperative complications and risk factors in 4255 patients who underwent bariatric and metabolic surgery in a single cente].
    Liang H; Lin SB; Guan W; Li C; Shen JJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Oct; 25(10):899-905. PubMed ID: 36245115
    [No Abstract]   [Full Text] [Related]  

  • 9. Ten-year outcomes after Roux-en-Y gastric bypass and sleeve gastrectomy: an observational nonrandomized cohort study.
    Jiménez A; Ibarzabal A; Moizé V; Pané A; Andreu A; Molero J; de Hollanda A; Flores L; Ortega E; Lacy A; Vidal J
    Surg Obes Relat Dis; 2019 Mar; 15(3):382-388. PubMed ID: 30772254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Weight Loss Results, Remission of Comorbidities and Nutritional Deficiencies of Sleeve Gastrectomy (SG), Roux-En-Y Gastric Bypass (RYGB) and One-Anastomosis Gastric Bypass (OAGB) on Type 2 Diabetic (T2D) Patients.
    Castro MJ; Jimenez JM; Carbajo MA; Lopez M; Cao MJ; Garcia S; Ruiz-Tovar J
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33092117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity Score Matching Sleeve Gastrectomy vs. Gastric Bypass with 5 Years of Follow-Up.
    Thaher O; Hukauf M; Stroh C
    Obes Surg; 2021 Dec; 31(12):5156-5165. PubMed ID: 34515946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis.
    Cho JM; Kim HJ; Lo Menzo E; Park S; Szomstein S; Rosenthal RJ
    Surg Obes Relat Dis; 2015; 11(6):1273-80. PubMed ID: 26071847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities.
    Ruiz-Tovar J; Carbajo MA; Jimenez JM; Castro MJ; Gonzalez G; Ortiz-de-Solorzano J; Zubiaga L
    Surg Endosc; 2019 Feb; 33(2):401-410. PubMed ID: 29943058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting relapse of type 2 diabetes after bariatric surgery in Sweden 2007-2015: a registry-based cohort study.
    Jans A; Szabo E; Näslund I; Ottosson J; Näslund E; Stenberg E
    Surg Obes Relat Dis; 2022 Mar; 18(3):305-312. PubMed ID: 34974997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of Type 2 Diabetes Mellitus (T2DM) after Sleeve Gastrectomy (SG), One-Anastomosis Gastric Bypass (OAGB), and Roux-en-Y Gastric Bypass (RYGB): A Systematic Review.
    Balasubaramaniam V; Pouwels S
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241216
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of bariatric surgery on insulin-treated type 2 diabetes patients.
    Lemus R; Karni D; Hong D; Gmora S; Breau R; Anvari M
    Surg Endosc; 2018 Feb; 32(2):990-1001. PubMed ID: 28842774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy.
    Nielsen HJ; Nedrebø BG; Fosså A; Andersen JR; Assmus J; Dagsland VH; Dankel SN; Gudbrandsen OA; Fernø J; Hjellestad I; Hjermstad MJ; Kolotkin RL; Thorsen HL; Mellgren G; Flølo TN
    Int J Obes (Lond); 2022 Apr; 46(4):739-749. PubMed ID: 34974544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loop versus Roux-en-Y duodenojejunal bypass with sleeve gastrectomy for type 2 diabetes: short-term outcomes of a single-center randomized controlled trial.
    Lin S; Li C; Shen J; Guan W; Liang H
    Surg Obes Relat Dis; 2022 Nov; 18(11):1277-1285. PubMed ID: 35985975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbial Predictors of Type 2 Diabetes Remission Following Bariatric Surgery.
    Davies N; O'Sullivan JM; Plank LD; Murphy R
    Obes Surg; 2020 Sep; 30(9):3536-3548. PubMed ID: 32447634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion to Roux-en-Y gastric bypass versus one-anastomosis gastric bypass after a failed primary gastric band: a matched nationwide study.
    Akpinar EO; Nienhuijs SW; Liem RSL; Greve JWM; Marang-van de Mheen PJ;
    Surg Obes Relat Dis; 2022 Jul; 18(7):948-956. PubMed ID: 35659796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.